Bio-Rad Laboratories, Inc. BIO-B Stock
Bio-Rad Laboratories, Inc. Price Chart
Bio-Rad Laboratories, Inc. BIO-B Financial and Trading Overview
| Bio-Rad Laboratories, Inc. stock price | 290 USD |
| Previous Close | 304.15 USD |
| Open | 304.15 USD |
| Bid | 293.17 USD x 8000 |
| Ask | 299.97 USD x 4000 |
| Day's Range | 304.15 - 304.15 USD |
| 52 Week Range | 244.54 - 321.12 USD |
| Volume | 11 USD |
| Avg. Volume | 96 USD |
| Market Cap | 8.14B USD |
| Beta (5Y Monthly) | 1.08 |
| PE Ratio (TTM) | 50.523254 |
| EPS (TTM) | 6.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BIO-B Valuation Measures
| Enterprise Value | 7.95B USD |
| Trailing P/E | 50.523254 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 4.23 |
| Price/Sales (ttm) | 3.1428008 |
| Price/Book (mrq) | 1.1909983 |
| Enterprise Value/Revenue | 3.071 |
| Enterprise Value/EBITDA | 17.88 |
Trading Information
Bio-Rad Laboratories, Inc. Stock Price History
| Beta (5Y Monthly) | 1.08 |
| 52-Week Change | 21.62% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 321.12 USD |
| 52 Week Low | 244.54 USD |
| 50-Day Moving Average | 285.74 USD |
| 200-Day Moving Average | 289.72 USD |
BIO-B Share Statistics
| Avg. Volume (3 month) | 96 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 5.06M |
| Float | 20.91M |
| Short Ratio | 0.16 |
| % Held by Insiders | 98.22% |
| % Held by Institutions | 0.077% |
| Shares Short | 14 |
| Short % of Float | 0.010% |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 6.51% |
| Operating Margin (ttm) | 5.75% |
| Gross Margin | 52.00% |
| EBITDA Margin | 17.17% |
Management Effectiveness
| Return on Assets (ttm) | 1.79% |
| Return on Equity (ttm) | 2.49% |
Income Statement
| Revenue (ttm) | 2.59B USD |
| Revenue Per Share (ttm) | 95.8 USD |
| Quarterly Revenue Growth (yoy) | 1.09% |
| Gross Profit (ttm) | 1.35B USD |
| EBITDA | 444.8M USD |
| Net Income Avi to Common (ttm) | 168.8M USD |
| Diluted EPS (ttm) | 6.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.56B USD |
| Total Cash Per Share (mrq) | 58.47 USD |
| Total Debt (mrq) | 1.38B USD |
| Total Debt/Equity (mrq) | 20.12 USD |
| Current Ratio (mrq) | 3.208 |
| Book Value Per Share (mrq) | 255.374 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 510.4M USD |
| Levered Free Cash Flow (ttm) | 229.76M USD |
Profile of Bio-Rad Laboratories, Inc.
| Country | United States |
| State | CA |
| City | Hercules |
| Address | 1000 Alfred Nobel Drive |
| ZIP | 94547 |
| Phone | 510 724 7000 |
| Website | https://www.bio-rad.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 7450 |
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Q&A For Bio-Rad Laboratories, Inc. Stock
What is a current BIO-B stock price?
Bio-Rad Laboratories, Inc. BIO-B stock price today per share is 290 USD.
How to purchase Bio-Rad Laboratories, Inc. stock?
You can buy BIO-B shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bio-Rad Laboratories, Inc.?
The stock symbol or ticker of Bio-Rad Laboratories, Inc. is BIO-B.
Which industry does the Bio-Rad Laboratories, Inc. company belong to?
The Bio-Rad Laboratories, Inc. industry is Medical Devices.
How many shares does Bio-Rad Laboratories, Inc. have in circulation?
The max supply of Bio-Rad Laboratories, Inc. shares is 26.76M.
What is Bio-Rad Laboratories, Inc. Price to Earnings Ratio (PE Ratio)?
Bio-Rad Laboratories, Inc. PE Ratio is 48.17275600 now.
What was Bio-Rad Laboratories, Inc. earnings per share over the trailing 12 months (TTM)?
Bio-Rad Laboratories, Inc. EPS is 6.02 USD over the trailing 12 months.
Which sector does the Bio-Rad Laboratories, Inc. company belong to?
The Bio-Rad Laboratories, Inc. sector is Healthcare.
Bio-Rad Laboratories, Inc. BIO-B included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE Composite Index
NYA
US
|
23463.63 USD — |
-0.56
|
— — | 23332.58 USD — | 23596.22 USD — | — - | — — |
- {{ link.label }} {{link}}


